Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer

Circulating tumor DNA (ctDNA) is reported to be promising in localized colorectal cancer (CRC). The present study aimed to retrospectively evaluate the impact of ctDNA in patients with a resected stage II CRC from the PROGIGE 13 trial with available paired tumor and blood samples. A group of recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Grancher, Adrien, Beaussire, Ludivine, Manfredi, Sylvain, Le Malicot, Karine, Dutherage, Marie, Verdier, Vincent, Mulot, Claire, Bouché, Olivier, Phelip, Jean-Marc, Levaché, Charles-Briac, Deguiral, Philippe, Coutant, Sophie, Sefrioui, David, Emile, Jean-François, Laurent-Puig, Pierre, Bibeau, Frédéric, Michel, Pierre, Sarafan-Vasseur, Nasrin, Lepage, Côme, Di Fiore, Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685416/
https://www.ncbi.nlm.nih.gov/pubmed/36439476
http://dx.doi.org/10.3389/fonc.2022.973167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685416/
https://www.ncbi.nlm.nih.gov/pubmed/36439476
http://dx.doi.org/10.3389/fonc.2022.973167

Ejemplares similares